KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Net Margin (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Net Margin readings, the most recent being 241.8% for Q4 2025.

  • On a quarterly basis, Net Margin rose 345.0% to 241.8% in Q4 2025 year-over-year; TTM through Dec 2025 was 183.81%, a 5713.0% increase, with the full-year FY2025 number at 183.81%, up 5713.0% from a year prior.
  • Net Margin hit 241.8% in Q4 2025 for Ginkgo Bioworks Holdings, down from 207.93% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 63.34% in Q3 2024 to a low of 1080.85% in Q4 2021.
  • Median Net Margin over the past 5 years was 243.52% (2024), compared with a mean of 351.17%.
  • Biggest five-year swings in Net Margin: crashed -94193bps in 2021 and later skyrocketed 90475bps in 2022.
  • Ginkgo Bioworks Holdings' Net Margin stood at 1080.85% in 2021, then soared by 84bps to 176.1% in 2022, then crashed by -246bps to 609.1% in 2023, then soared by 60bps to 245.25% in 2024, then increased by 1bps to 241.8% in 2025.
  • The last three reported values for Net Margin were 241.8% (Q4 2025), 207.93% (Q3 2025), and 121.56% (Q2 2025) per Business Quant data.